Evidence map›Paper›PMID 41143147›Full record

ReviewFrontiers in human neuroscience2025

Beauty in the shadow of neurodegenerative disease: a narrative review on aesthetic experience, neural mechanisms, and therapeutic frontiers.

Andrea Calderone, Rosaria De Luca, Rosalia Calapai, Alessio Mirabile, Angelo Quartarone, Rocco Salvatore Calabrò

Abstract readReview
In one paragraph

Review in Frontiers in human neuroscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Andrea CalderoneIRCCS Centro Neurolesi Bonino Pulejo, Messina, Italy.
Rosaria De LucaIRCCS Centro Neurolesi Bonino Pulejo, Messina, Italy.
Rosalia CalapaiIRCCS Centro Neurolesi Bonino Pulejo, Messina, Italy.
Alessio MirabileIRCCS Centro Neurolesi Bonino Pulejo, Messina, Italy.
Angelo QuartaroneIRCCS Centro Neurolesi Bonino Pulejo, Messina, Italy.
Rocco Salvatore CalabròIRCCS Centro Neurolesi Bonino Pulejo, Messina, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neuroaesthetics, an emerging field at the intersection of neuroscience, psychology, and the arts, offers new perspectives on the biological and cognitive mechanisms of aesthetic experience. This narrative review explores the convergence of neuroaesthetics and neurodegenerative disorders, focusing on Alzheimer's disease, Parkinson's disease, frontotemporal dementia, and Huntington's disease. Drawing on evidence from neuroimaging, neuropsychology, and clinical studies, we examine how neurodegenerative processes differentially disrupt the neural systems of the "aesthetic triad": sensory-motor, emotion-valuation, and meaning-knowledge. Such disruptions not only impair patients' ability to perceive and create art but may also reveal unexpected creative capacities. We discuss the therapeutic potential of arts-based interventions, highlighting the benefits of personalized and technology-driven approaches, including immersive virtual reality and digital art platforms, to enhance neurorehabilitation and psychological wellbeing. The "Michelangelo effect," where engagement in meaningful aesthetic activities supports learning, motivation, and resilience, exemplifies this translational potential. Our synthesis underscores clinical, neuroscientific, and rehabilitative implications, while noting ongoing challenges such as the need for standardized outcomes and interdisciplinary collaboration. Integrating neuroaesthetic principles into neurorehabilitation may help preserve cognitive and motor functions and enrich quality of life and self-concept in people with neurodegenerative disease. Future research should optimize these approaches to ensure meaningful benefits for patients.

Indexed as

aesthetic experienceAlzheimer’s diseasefrontotemporal dementiaHuntington’s diseaseneuroaestheticsneurodegenerative diseasesneurorehabilitationParkinson’s disease

Identifiers

PMID41143147
PMCPMC12546065

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.